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Abstract
RNA processing events that take place on the transcribed pre-mRNA include capping, splicing, editing, 39 processing, and
polyadenylation. Most of these processes occur co-transcriptionally while the RNA polymerase II (Pol II) enzyme is engaged
in transcriptional elongation. How Pol II elongation rates are influenced by splicing is not well understood. We generated a
family of inducible gene constructs containing increasing numbers of introns and exons, which were stably integrated in
human cells to serve as actively transcribing gene loci. By monitoring the association of the transcription and splicing
machineries on these genes in vivo, we showed that only U1 snRNP localized to the intronless gene, consistent with a
splicing-independent role for U1 snRNP in transcription. In contrast, all snRNPs accumulated on intron-containing genes,
and increasing the number of introns increased the amount of spliceosome components recruited. This indicates that
nascent RNA can assemble multiple spliceosomes simultaneously. Kinetic measurements of Pol II elongation in vivo, Pol II
ChIP, as well as use of Spliceostatin and Meayamycin splicing inhibitors showed that polymerase elongation rates were
uncoupled from ongoing splicing. This study shows that transcription elongation kinetics proceed independently of splicing
at the model genes studied here. Surprisingly, retention of polyadenylated mRNA was detected at the transcription site after
transcription termination. This suggests that the polymerase is released from chromatin prior to the completion of splicing,
and the pre-mRNA is post-transcriptionally processed while still tethered to chromatin near the gene end.
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Introduction
The processes of transcription and RNA processing are co-
transcriptionally integrated [1–7]. A variety of studies have
demonstrated that pre-mRNA splicing is coupled to transcription
and that intron removal can occur at the site of transcription while
the polymerase is still engaged in active transcription. Other
mRNA processing events such as 59 capping and 39-end formation
are also coupled to transcription.
A unique feature of the eukaryotic RNA Pol II is the presence of
a long and highly conserved tail at the C-terminus of the large
subunit (Rbp1) of the polymerase, termed the CTD (carboxy-
terminal repeat domain). It is proposed that the CTD serves as a
‘‘jumping board’’ for protein factors that assemble on the nascent
transcript as it emerges from the polymerase [8–10]. For instance,
certain splicing factors from the SR protein family were found
associated with the phosphorylated CTD [11–14]. SR proteins are
most probably not associated with the transcriptional initiation
complex but join in only after the elongation related CTD-
phosphorylation has begun. This was demonstrated by showing
that RNA Pol II poised at the Fos gene promoter is not associated
with SR proteins when the gene is in an uninduced state, and only
after transcription had begun were SR proteins recruited [15].
Chromatin immunoprecipitation (ChIP) experiments have also
demonstrated the association of RNA processing factors with
transcribing genes [16–19].
Co-transcriptional splicing implies that splicing, at least in part,
should occur at the site of transcription. This is supported by
kinetic studies showing that splicing is completed within a short
,5–10 min time-frame from the time of transcription, and these
times are not influenced by intron length [20–24]. Splicing factors
are dynamically recruited to active gene loci [25–29]. The kinetics
of transcription can influence alternative splice site selection.
Polymerase slowdown and pausing affected the pattern of
alternative splicing in vivo as seen with a mutant polymerase
form that was intrinsically slow-elongating and favored the
inclusion of an exon [30]. The current model is that slowing
down of the polymerase or polymerase pausing leads to the
selection of a weak splice site [1,31].
In order to examine the opposite relationship, namely whether
the kinetics of the elongating RNA Pol II can be influenced by
splicing events occurring co-transcriptionally on the associated pre-
mRNA, we generated a series of comparable cell lines harboring
inducible gene constructs that contain increasing numbers of introns
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and exons. These genes were stably integrated into a human cell line
and formed tandem arrays containing multiple copies of the
integrated gene, thereby creating a genomic locus that upon
transcriptional activation is easily monitored using live-cell imaging.
Such transcription sites have been used previously to analyze the
kinetics of recruitment of a variety of nuclear factors to actively
transcribing genes (reviewed in [32,33]). Previous work has
demonstrated that the real-time kinetics of RNA Pol II elongation
on an active gene can be faster than measured by many biochemical
measurements, and is coupled to stochastic pauses of the enzyme
[34,35]. Recent studies have confirmed that Pol II elongation can
proceed at rates of 3–4 kb/min [21,22,36].
In this study we used the above in vivo approach to examine Pol
II elongation rates either on genes that do not contain an intron
and therefore are not expected to recruit the spliceosome to the
nascent transcript or on genes containing varying numbers of
intron/exons and that undergo co-transcriptional splicing. We
show that polymerase elongation kinetics are not modulated by
splicing events taking place on the emerging pre-mRNA, that
increased splicing leads to an increase in the splicing factors
recruited to the mRNA, and that post-transcriptional splicing can
proceed at the site of transcription without the presence of the
polymerase.
Results
Generation of Cell Lines with Integrated Intron-
Containing Genes
In order to examine the elongation kinetics of RNA Pol II
during splicing, we generated the following gene constructs. The
first construct consisted of the human b-globin mini-gene with three
exons and two introns and was therefore designated E3 (Figure 1A)
[37,38]. Exon 3 was truncated and fused in-frame to a cyan
fluorescent protein (CFP) coding region containing the peroxi-
somal targeting tripeptide Ser-Lys-Leu (SKL) in its C-terminus
[39], thereby generating cyan fluorescing peroxisomes throughout
the cytoplasm, indicative of productive gene expression. Immedi-
ately downstream were a series of 18 MS2 sequence-repeats.
When transcribed, these repeats form 18 stem-loops in the mRNA
and provide high-affinity binding sites for the MS2 coat protein
[40,41]. The detection of these mRNAs in vivo is accomplished by
the binding of dimers of the YFP-MS2 coat-protein to each stem-
loop, thereby forming fluorescently labeled mRNAs [42]. This
occurs simultaneously during active transcription [34,41].
b-globin was chosen as a model gene since it has been extensively
used for in vitro splicing assays [43]. In this manner we could use a
system that is close to the endogenous state of a gene. The first
intron of b-globin is short (131 nt), while most typical genes have a
long first intron [44]. The length of the second b-globin intron is
992 nt, which is close to the median size of internal introns
(,1,400 nt) [44]. Thereby, we could use repeats of the second
intron to generate additional genes containing increasing numbers
of introns.
In order to compare between genes, we generated additional
gene constructs (Figure 1A): (a) E1 – an intronless gene in which
exons 1, 2 and their introns were deleted, thereby leaving part of
exon 3 + CFP-SKL to serve as a single exon; and (b) E4, in which
intron 2, flanked by the splice sites and part of exons 2 and 3, was
duplicated, thereby forming a gene construct with 4 exons and 3
introns. The E6 construct (containing another two repeats of
intron 2) will be described later on. All the constructs were under
the inducible control of the Tet-On system. In the presence of the
rtTA (Tet-On) transactivator and the addition of doxycycline (dox)
to the medium, transcription was induced.
Each of the constructs was stably integrated into human U2OS
Tet-On stable cells. The different sized gene constructs produced
the correctly spliced mRNAs as seen by RT-PCR on mRNA
extracted from the three cell lines following transcriptional
activation by dox: E3 = 2,279 nt (unspliced 3,402 nt), E4 =
2,321 nt (unspliced 4,436 nt) (Figure 1B). The E1 mRNA
(1,941 nt) did not undergo splicing. The genes were co-integrated
with a plasmid containing 256 lac operator repeats (lacO) in order
to enable the detection of the genomic locus of integration [29,45].
Using a fusion protein of the lac repressor protein (LacI), e.g. RFP-
LacI, the genomic locus was tagged, allowing the detection of the
integration locus independent of the transcriptional status of the
gene. Selection of positive stable clones was performed after
induction with dox and identification of cytoplasmic CFP-
peroxisomes in all cell clones (Figures 1C and S1), altogether
indicating accurate transcription, splicing, export, and translation.
Co-integration of the 256 lacO repeats was verified by the
expression of RFP-lacI and the detection of single genomic
integration sites (Figure 1C). YFP-MS2-labeled mRNAs were
detected at the transcription site, as well as in the nucleoplasm and
the cytoplasm as expected (Figure 1C). Several stable clones were
kept for each gene, and we proceeded to work with three cell lines
designated E1, E3, and E4, in accordance with the integrated
gene.
Stable transfection results in the integration of multiple copies of
the gene construct at one genomic locus that is termed a ‘‘tandem
gene array,’’ which is useful for live-cell imaging experiments of
active transcription sites [32]. We confirmed that RNA Pol II in
both active phosphorylated forms was recruited to the transcrip-
tion sites using the H14 (CTD phosphorylated on serine 5), H5
Author Summary
The pre-mRNA emerging from RNA polymerase II during
eukaryotic transcription undergoes a series of processing
events. These include 59-capping, intron excision and exon
ligation during splicing, 39-end processing, and polyade-
nylation. Processing events occur co-transcriptionally,
meaning that a variety of enzymes assemble on the pre-
mRNA while the polymerase is still engaged in transcription.
The concept of co-transcriptional mRNA processing raises
questions about the possible coupling between the
transcribing polymerase and the processing machineries.
Here we examine how the co-transcriptional assembly of
the splicing machinery (the spliceosome) might affect the
elongation kinetics of the RNA polymerase. Using live-cell
microscopy, we followed the kinetics of transcription of
genes containing increasing numbers of introns and
measured the recruitment of transcription and splicing
factors. Surprisingly, a sub-set of splicing factors was
recruited to an intronless gene, implying that there is a
polymerase-coupled scanning mechanism for intronic
sequences. There was no difference in polymerase elonga-
tion rates on genes with or without introns, suggesting that
the spliceosome does not modulate elongation kinetics.
Experiments including inhibition of splicing or transcription,
together with stochastic computational simulation, dem-
onstrated that pre-mRNAs can be retained on the gene
when polymerase termination precedes completion of
splicing. Altogether we show that polymerase elongation
kinetics are not affected by splicing events on the emerging
pre-mRNA, that increased splicing leads to more splicing
factors being recruited to the mRNA, and that post-
transcriptional splicing can proceed at the site of transcrip-
tion in the absence of the polymerase.
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Figure 1. Generating a cell system with comparable genes containing increasing numbers of introns. (A) Gene constructs containing
increasing numbers of introns and exons of the human b-globin mini-gene were generated and termed E1, E3, E4, and E6. Common to all the genes
are: Tet-inducible promoter (orange; Tet responsive element (TRE), minimal promoter (Pmin)) that is induced in the presence of rtTA (yellow) and
Pol II Dynamics during Splicing
PLoS Biology | www.plosbiology.org 3 January 2011 | Volume 9 | Issue 1 | e1000573
(CTD phosphorylated on serine 2), and 8WG16 antibodies
(specific to the CTD repeats) (Figures 1D and S2A,B). RNA
FISH with probes to different regions in the pre-mRNA and
mRNA were used to detect the distribution of the mRNAs in the
cells following dox induction. Probes to exon 1, the CFP coding
region (exon 3), or the MS2 region (39UTR) of the E3 gene,
detected the active transcription sites as well as cytoplasmic
mRNAs in induced cells, and some nuclear signal, suggesting
robust nucleo-cytoplasmic transport of the mRNAs to the
cytoplasm (Figure 1E). No RNA FISH signal was seen in un-
induced cells. Video S1 shows the activation of transcription,
nucleo-cytoplasmatic transport of the tagged mRNA, and the
appearance of the CFP peroxisomes in the cytoplasm. Altogether,
we generated a series of cell lines in which the kinetics of
transcription could be monitored on integrated genes in real-time.
Co-Transcriptional Splicing Occurs at the Site of
Transcription
Probes to the first or second intron regions displayed signal only
at the sites of transcription without additional signal in the
nucleoplasm or cytoplasm (Figure 2A,B), showing that the splicing
of introns occurred at the site of transcription. In order for co-
transcriptional splicing to occur, splicing factors must be recruited
to the pre-mRNA either by diffusing from the nucleoplasm or
possibly via the CTD of RNA Pol II. A previous proteomic study
immunopurified more than 100 proteins associated with RNA Pol
II in a non-transcribing extract [46], among them U1 snRNP
components and factors of the SR family. In order to assay the
recruitment of splicing factors in vivo we examined whether
different factors were enriched on the active E3 and E4 gene
arrays, using immunofluorescence to endogenous proteins or
expression of fluorescently-tagged versions of these proteins.
snRNPs, splicing factors, and other RNA processing factors were
detected (Figures S2C–J and S3). These data are summarized in
Table 1. In addition, using RNA FISH probes specific to the
different snRNAs we could detect U1, U2, U4, U5, and U6
snRNAs at the site (Figures 2C–E, S2D–E, and Table 1). Not all
molecules expected to be present at the transcription sites were
detected, e.g. PSF, p54nrb, and 7SK-RNA (Figure S3B,C, and F).
We conclude that co-transcriptional splicing is occurring on the
pre-mRNAs associated with the active transcription sites, and that
the mRNA processing factors are recruited either via association
with the transcribing polymerase or directly with the nascent
mRNAs.
The U1 snRNP Is Recruited to an Intronless Gene
We then tested for the recruitment of the spliceosomal U
snRNPs to the intronless E1 gene. Using an antibody that
recognizes the 2,2,7-trimethylguanosine (m3G) cap of snRNA
(anti-TMG) we could detect TMG staining on the transcription
site of E1 (Figure S4A). RNA FISH showed that U1 snRNA was
present on the site, as well as the U1A protein (Figures 2F and
S4B). However, all other snRNAs or U2AF65 were not found on
the E1 sites (Figure 2G–H, S4C–E and Table 1).
The recruitment of U1 snRNA to the E1 and E3 genes was
measured and compared by correlating the intensity of the U1 and
U2 signals on the transcription site to the same two signals within
the nucleoplasm. In the nucleoplasm we expected to find co-
localization of U1 and U2 snRNA signals, since spliced genes are
predominant. In the case of the E3 and E4 genes, the U1/U2
correlation at the transcription site was the same as in the
nucleoplasm (Figure 2I). However, in the case of the E1 gene a
different correlation was observed between U1 and U2 at the
transcription site compared to the U1/U2 nucleoplasmic ratio
(Figure 2J). We then quantified this recruitment. The measured
ratio of U1 and U2 snRNA signals on the different genes
demonstrated a constant ratio between U1 and U2 on the intron-
containing genes (E3, E4, and E6), while on the E1 gene the
presence of U1 snRNA was dominant and U2 was not present
(Figure 2K). Interestingly in a recent study, the association of U1
components on a gene construct in which splicing did not take place
due to mutations in the 59- and 39-splice sites was demonstrated
[47]. We therefore conclude that U1 snRNPs are associated with
the transcriptional machinery on all transcribing genes, no matter
whether the pre-mRNA contains introns or not, probably through
interactions with the CTD of the active polymerase [46,47].
The Effect of Co-Transcriptional Splicing on Pol II
Elongation Kinetics
After showing that pre-mRNA splicing is taking place at the site
of transcription in the E3 and E4 genes, we examined whether
polymerase elongation kinetics differed between the intronless and
intron-containing genes. We used the previously described in vivo
elongation assay [34,35,41] to measure the kinetics of RNA Pol II
on the three genes. In this assay, active transcription sites are
detected with the YFP-MS2 coat protein. This fluorescent signal at
the transcription site consists of the steady state kinetics of mRNA
synthesis as well as mRNA release from the site. Using a
fluorescence recovery after photobleaching (FRAP) approach,
the YFP-MS2 signal at the transcription site is photobleached and
the recovery of the YFP-MS2 signal is monitored over time.
Fluorescence recovery signifies the generation of new MS2 stem-
loops in the nascent transcripts and their binding by fluorescent
YFP-MS2 molecules entering from the surrounding nucleoplasm
(Figure 3A and 3B).
This same approach was implemented on the E1, E3, and E4
genes. The cell lines were co-transfected with RFP-LacI and YFP-
MS2, and transcription was induced by dox for at least 6 h until
transcription reached steady state. Active transcription sites at
steady state did not show any significant difference in YFP-MS2
intensity for at least 20 min. Using a 3D-FRAP microscope system
we could photobleach the transcription site (YFP-MS2 signal) and
continue to detect the gene locus using the RFP-LacI DNA label.
The advantage of using the 3D-FRAP microscope is that rapid
doxycycline (dox); the genes consist of the b-globin intron and exon sequences (exon 1, purple; exon 2, green; exon 3, pink) in frame with a CFP-SKL
peroxisomal protein (blue), and a series of 18 MS2 repeats in the 39UTR (cyan) for the in vivo labeling of the mRNA via binding of YFP-MS2 proteins
(green stars). The 39-end of the gene contains a polyA site. Intron sizes, the total size of the gene, the MS2 repeat region, and the 39UTR are marked.
(B) RT-PCR showing the production of the correctly spliced E3, E4, and E6 mRNAs. GAPDH was used as a control. Sizes(nt) are marked above the
bands. (C) E3 cell induced with dox for 12 h (activation times are similar in all experiments unless indicated otherwise) showing the gene locus
marked by RFP-LacI (red), the transcribed mRNA at the transcription site and throughout the cell labeled with YFP-MS2 (yellow), and the CFP-SKL
protein product in cytoplasmic peroxisomes (cyan). (D) Actively transcribing transcription sites (yellow, YFP-MS2 tagged mRNA) and gene locus (red,
RFP-LacI) show the recruitment of endogenous RNA Pol II (purple) by immunofluorescence with the H14 Ab that detects initiating polymerases.
Enlargements show the overlay at the transcription site. CFP-peroxisomes are seen in cyan. (E) RNA-FISH showing mRNAs detected throughout an E3
cell with fluorescent probes to the first exon (red), the CFP exon (exon 3, purple), and the MS2 repeats (green). Scheme shows the probe binding sites
and the enlargement of the transcription site (bar, 5 mm).
doi:10.1371/journal.pbio.1000573.g001
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Figure 2. Co-transcriptional splicing occurs at the site of transcription. (A) A probe to the first intron or (B) the second intron (purple) was
detected in an E3 cell only at the transcription site while the mature mRNA was detected throughout the cell (probe to exon 1, red). Schemes on the
right show the probe binding regions and an enlargement of the colocalized signals at the transcription site. (C–H) The recruitment of the core pre-
mRNA splicing machinery to active transcription sites was examined in E3 (left column) and E1 (right column) cells. RNA-FISH with an MS2 probe
(yellow) shows the active transcription sites together with snRNA probes in red: (C and F) U1 snRNA, (D and G) U2 snRNA, and (E and H) U6 snRNA.
Enlargements show the signals at the transcription sites. Plots on the right depict the degree of colocalization of the signals at the transcription site
across the blue line. (I) RNA-FISH signal of U1 and U2 snRNAs (middle) at the active transcription site (seen with the MS2 probe, left) of an E3 cell and
(J) an E1 cell were measured. The green box shows a random nucleoplasmic area, and the red and blue boxes show the area of the transcription site.
The plot shows the correlation of the U1 and U2 snRNA signals at the transcription site (red and blue dots) in comparison to the nucleoplasm (green
dots) (bar, 5 mm). (K) The ratio between U1 and U2 snRNA signals measured by RNA-FISH, at the transcription sites of all genes. The data in (I), (J), and
(K) show a constant correlation in the intron-containing genes, and no correlation in the intronless E1 gene, meaning that U1 and not U2 is recruited
even to an intronless gene.
doi:10.1371/journal.pbio.1000573.g002
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3 dimensional (3D)-imaging over time (4D) could be performed.
Thereby, the signal of the whole nuclear volume could be collected
with no effect on the measurements, and motion of the
transcription site was easily tracked (Figure 3A and Video S2).
This is in comparison to most confocal microscopes that collect the
information only in 2 dimensions, and therefore measurements
would be sensitive to any DNA motion in the z-axis.
Transcription sites were followed for extended periods (up to
30 min). The YFP-MS2 signal intensity on the transcription sites
was quantified using a tracking algorithm. We measured recovery
kinetics on the transcription sites of all the three gene-types in
order to examine whether different elongation kinetics could be
identified. We compared a polymerase passing through the MS2
region of an intronless E1 gene to a polymerase moving through
the MS2 region of the intron-containing E3/E4 genes that
undergo co-transcriptional splicing (after the exons and introns are
transcribed). The FRAP recovery curves measured on the E1, E3,
and E4 genes all showed similar recovery kinetics (Figure 3C),
indicating that the polymerase transcribing the MS2 region was
not affected by the presence of active splicing from the upstream
sequences. We conclude that upstream splicing events do not
necessarily affect the elongation kinetics on our model genes.
However, it is possible that other differences such as in intron
sequence or intron size (e.g. the b-globin first intron is shorter than
average) might cause some effect on elongation. These experi-
ments were performed on several microscope stations to verify
reproducibility (Figure S5). Altogether, these measurements
indicate that polymerase transcription rates are not modulated
by the co-transcriptionally assembled spliceosomal machinery.
Increasing Intron Numbers Leads to an Increase in
Spliceosome Component Recruitment
We examined a similar gene construct in which additional
introns and exons were very closely spaced. Thereby, we expected
transcription to end before the completion of splicing of all introns,
which would allow the further examination of elongation kinetics.
The E6 gene was generated using the E4 construct and consisted
of 6 exons and 5 introns by using duplications of intron 2
(Figure 1A). In this manner, we generated a gene with 6 exons
(close to the 8 exon median size of genes [44]). The E6 mRNA
(2,437 nt) was correctly spliced (unspliced 6,536 nt, Figure 1B), the
CFP-SKL peroxisomal protein was expressed normally (Figure S1
and Video S1), and similar recruitment of splicing factors was
observed (unpublished data).
First, we verified that there was an increase in accumulation of
introns at the transcription site of the E6 gene compared to the
other genes, as expected. 3D volumes of RNA-FISH labeled cells
were collected, deconvolved, and analyzed. We calculated the
fluorescence ratio of intron 2 in comparison to the last exon (CFP
exon), in all the cell lines. Higher levels of introns generated were
detected on the E6 gene (Figure 4A) compared to the other genes.
As expected, there was a gradual accumulation of intron 2 at the
active transcription sites in dependence to the number of introns in
each gene.
We next asked whether there would be increased accumulation
of the splicing machinery on genes containing more introns. We
therefore quantified the relative amounts of the splicing machinery
(U snRNAs) that accumulated on each transcript using 3D
volumes of RNA-FISH labeled cells (Figure 4B and 4C).
Quantification of the fluorescence ratio of U5 or U6 snRNAs in
comparison to the first exon present in each nascent transcript
demonstrated a higher accumulation of snRNAs that was
dependent on the number of introns in the gene. This indicated
that the addition of exons resulted in an increase in the
recruitment of the splicing machinery per transcript. These data
also imply that the elongation machinery does not wait for each
splicing event to complete before moving forward on the gene, but
rather continues to elongate while more spliceosomal units
accumulate on the transcript.
Table 1. Examination of the proteins and RNAs that are recruited to intron-containing and intronless genes.
Recruited to Intron-Containing
Transcription Sites (E3/E4/E6)
Not Recruited to Intron-Containing
Transcription Sites (E3/E4/E6)
Recruited to an Intronless
Gene (E1)
Not Recruited to an
Intronless Gene (E1)
Active polymerase II (H14) PSF Active polymerase II (H14) U2 snRNA
Active polymerase II (H5) p54nrb Active polymerase II (H5) U4 snRNA
Polymerase II CTD repeats (8WG16) 7SK RNA Polymerase II CTD repeats (8WG16) U5 snRNA
2,2,7-trimethylguanosine (m3G)
(anti-TMG)
2,2,7-trimethylguanosine (m3G)
(anti-TMG)
U6 snRNA
U1 snRNA U1 snRNA U2AF65
U2 snRNA U1A
U4 snRNA
U5 snRNA
U6 snRNA
U1A
U2AF65
SF2/ASF
SC35
9G8
TLS
PTB
Cyclin-T1
doi:10.1371/journal.pbio.1000573.t001
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The E6 Gene Exhibits Slower Recovery Kinetics
Next, polymerase kinetics on the E6 gene were measured.
Interestingly YFP-MS2 FRAP curves showed significantly slower
recovery kinetics compared to the previous measurements on the
E1, E3, and E4 genes (Figure 4D). In order to verify that this was
not a clone-related difference, and that the measurements were not
affected by the number of gene units in the tandem array or from
the DNA integration site, we compared two different E6 clones,
E6-22 (40 gene copies) to clone E6-3 (9 gene copies). The copy
number of gene integration in each cell line was quantified by real-
time PCR on genomic DNA. We found that both E6 clones
recovered with identical and relatively slower kinetics (Figure S6A
and S6B).
To identify the cause for the kinetic difference between the
genes, we analyzed the measured FRAP recovery curves. Two
previous studies have used this MS2 FRAP approach to measure
Pol II transcription rates on specific genes [34,41]. The assay
measures the recovery of fluorescence as the polymerase
transcribes the MS2 region right after the exons and introns are
transcribed (Figure 3B). The recovery signal shows bi-phasic
kinetics (Figure S7A), which best fit to two exponentials. This
implies that the measurements are detecting two processes that are
occurring in parallel, which require the interpretation of the
significance of each phase in the curves. The abovementioned
studies have used extensive modeling to study such FRAP curves
and demonstrated that the fast phase of fluorescence recovery is
generated by the actively elongating polymerases. The slow phase
of recovery was explained as either a population of polymerases in
a paused state along the gene [34] or a termination delay [41].
The slow kinetics on the E6 gene could therefore be caused either
by polymerase slowdown or by retention of the mRNA after
termination. This was further tested.
We first examined whether the kinetic effect was due to a
change in polymerase activity. FRAP of the active polymerase
transcribing on the E3 and E6 genes was analyzed using a
transfected GFP-Pol II that was recruited to the active genes.
Similar FRAP recovery kinetics were measured on both genes
(Figure 5A). This measurement differs from the above measure-
ment of YFP-MS2 FRAP recovery. While the latter measures
elongation through the MS2 region only, Pol II FRAP
encompasses the whole polymerase transcriptional process on
the gene, ranging from initiation through elongation and
Figure 3. Comparison of transcriptional kinetics on active E1, E3, and E4 transcription sites. (A) An active transcription site (YFP-MS2,
bottom cell) was photobleached and the fluorescence recovery was tracked over time (frames on right). These experiments were performed on a 3D
FRAP system (XZ and YZ representations are seen under and to the right of the original image, respectively). (B) Scheme of the elongation assay
showing bleaching of the YFP-MS2 proteins (yellow) bound to the mRNA and the recovery of fluorescence as new polymerases elongate through the
MS2 region. (C) Recovery curves of the YFP-MS2 FRAP measurements performed on E1, E3, and E4 transcription sites. Average of n.10 experiments
for each cell type with SDE.
doi:10.1371/journal.pbio.1000573.g003
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termination [34]. The Pol II FRAP measurements (Figure 5A)
indicated that the polymerases on E3 and E6 genes were
functioning with similar kinetics with regard to the general
transcriptional flow. However, since only the very slow recovery
phase is attributed to the elongating phase of the polymerase
(consists of only ,30% of the signal) [34], it is difficult to resolve
between the polymerase kinetics on E3 and E6. Therefore, we
obtained chromatin immunoprecipitation (ChIP) information to
compare the distribution of Pol II along the genes, which might
detect regions of paused polymerases. Using pull-down of the
polymerase with an anti-Pol II antibody followed by real-time
PCR on 7 different gene regions, we corroborated the polymerase
FRAP findings and demonstrated that there was no statistical
differences in the density of Pol II along the two genes (Figure 5B).
Additionally, from these data we can learn that the highest Pol II
density is found at the promoter and the polyA site, which is in
agreement with other studies [16]. Altogether, these results showed
that the detected kinetic change in E6 was not directly connected
to the polymerase.
Splicing Inhibition Relieves the Slow Kinetics on the E6
Gene
To examine whether the E6 kinetic delay was due to ongoing
splicing, we used two splicing inhibitors, Spliceostatin A (SSA) [48]
and Meayamycin [49]. SSA and Meayamycin are inhibitors of
pre-mRNA splicing via SF3b binding, which binds to the intron
branch-point and acts as a subcomplex in the U2 snRNP. SSA
treatment caused the accumulation and retention of unspliced pre-
mRNA in the nucleoplasm, which continued to accumulate in
nuclear speckles, as detected by RNA-FISH with an intron probe
(Figure 5C), as previously described [48]. We now show this same
Figure 4. Increased spliceosome recruitment and change in transcriptional kinetics in relation to increasing intron numbers. (A)
Quantification of the RNA-FISH signals showing the ratio of the second intron to the last exon (CFP region) on the different transcription sites (all
normalized to the E3 ratio). (B) A 3D representation of the deconvolved images of an RNA-FISH experiment in which MS2 mRNA (in yellow) and U5
snRNA (in red) were detected. The signals at the transcription site were measured for both channels. The elongated form of the signal is due to the
3D projection of the images. (C) Quantification of the RNA-FISH signal showing the ratio between transcription site associated U5 (blue dots) or U6
(red dots) snRNAs in comparison to exon 1 on the E3, E4, and E6 genes. Each dot represents a transcription site ratio. (D) FRAP recovery curves of YFP-
MS2 on E3 versus E6 genes with standard error bars (n.10).
doi:10.1371/journal.pbio.1000573.g004
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Figure 5. Dynamics of E6 mRNA are affected by active splicing and not by polymerase kinetics. (A) FRAP recovery curves of transfected
GFP-Pol II recruited to the E3 and E6 genes. (B) ChIP analysis of Pol II distribution along the E3 (blue bars) and E6 (red bars) genes. Black boxes under
the schemes indicate primer positions. The data were normalized to the promoter by setting the promoter value at 100%. A t-test for each primer set
showed no significant differences (p.0.05). (C) Inhibition of splicing by Spliceostatin (SSA) for 9 h showed that unspliced pre-mRNA (intron probe,
magenta) was distributed throughout the cell and in speckles (RNA-FISH on E6 cells) and was retained in the nucleus (bottom), whereas in untreated
cells pre-mRNA was detected only at the site of transcription (intron probe, magenta; exon probe, red) (bar, 5 mm). (D) SSA treatment (6 h) caused the
nuclear retention of intron-containing E3 mRNA (middle) versus the regular nucleo-cytoplasmatic dispersal of E1 intronless mRNA (right). Left,
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effect also for Meayamycin (Figure S8A). Interestingly, the
dispersal of the intronless E1 mRNA was not affected, and it did
not accumulate in speckles (Figure 5D). Then we measured YFP-
MS2 recoveries by FRAP on the E6 gene in untreated cells as
described above and incubated the same transcribing cells with
either SSA or with Meayamycin. Under both treatments the slow
kinetics of E6 were transformed to the regular kinetics of E3/E4/
E1 genes (Figure 5E and S8B), whereas splicing inhibition did not
cause any effect on the kinetics of the E3 gene (Figure 5E). On the
other hand, FRAP of GFP-Pol II in the presence of SSA on the E6
gene (Figure S8C), and ChIP experiments in the presence of SSA
(Figure 5F) did not show any change in kinetics. These results
demonstrate that splicing inhibition did not modify Pol II
distribution or kinetics along the genes. This emphasized that
the changes in kinetics between E6 and E3 genes were due to
active splicing events and were not connected to the elongation
activity of the polymerase.
RNA Splicing Can Lead to Retention of the Pre-mRNA on
the Transcription Site
The above experiments suggested that the slow recovery FRAP
curves of the YFP-MS2 experiments were due to a delay of the
nascent transcripts on the E6 sites caused by splicing but without
connection to the polymerase itself. First, we verified that the full
transcripts were 39-end processed and were present at the site of
transcription of all the genes prior to release. This was shown by
the recruitment of GFP-PABP2 to the active transcription sites and
by the presence of polyA tails as seen by RNA-FISH (Figure 6A
and 6B). RNA-FISH measurements of the ratio of polyA signal to
the last exon (CFP) on the sites showed that a constant ratio was
retained on all the transcription sites (Figure 6C), meaning that
there was no accumulation of mRNAs lacking polyA on the
different genes and no change in polyadenylation levels. This
suggested that there was an accumulation of transcripts that were
not attached to Pol II, at the transcription sites.
To characterize the delay time of the mRNAs on the E6 trans-
cription sites, we next examined the kinetics of mRNA release
from the gene. Actinomycin D (ActD) was added to actively
transcribing cells containing YFP-MS2 tagged transcription sites.
The ‘‘shut-down’’ of the transcription sites was monitored over
time under the microscope. Indeed, slower clearing of the mRNAs
from the gene was observed in E6 cells (t1/2 = 17 min) compared
to E3 cells (t1/2 = 7 min) and E4 (t1/2 = 8.9 min) (Figure 6D,
Video S3). This experiment correlates with the YFP-MS2 FRAP
measurements (Figure 4D) showing slower mRNA kinetics on the
E6 gene.
Finally, to demonstrate that only the mRNAs disconnected from
the polymerase were stalled on the E6 gene, we quantified the
intensity ratio of the polymerase signal and the mRNA signal on
the transcription sites using anti-Pol II immunofluorescence and
RNA-FISH to the first exon. If indeed each mRNA is attached to
one polymerase, we would expect a constant ratio for all cell lines.
However, we found that the proportion of mRNA to Pol II on E6
transcription sites was three times higher than on E3 and E4 sites
(Figure 6E). When SSA was added and splicing was inhibited, the
mRNA/Pol ratio on the E6 sites was reduced to the levels of E3
and E4 sites, meaning that under conditions of splicing inhibition,
the unspliced E6 pre-mRNAs were being released without stalling
similarly to the E3 and E4 mRNAs. These experiments implied
that in a situation like the E6 gene which contains closely spaced
introns, and in which the polymerase has finished transcribing yet
the pre-mRNA is not fully spliced, the mRNA is retained at the
transcription site until the completion of splicing.
To better understand the given observed results we simulated
the transcriptional process using a stochastic Monte-Carlo
simulation (Figure S9A and Video S4). The simulation mimicked
the transcriptional process based on the transcriptional models
described in the previous studies [34,41]. Kinetic parameters were
obtained by fitting the simulations to the experimental FRAP
curves of E3 (Figures 6F). See Material and Methods for
explanation of parameter scanning. The parameters that gave
the best fit were: an elongation speed of 3.6 kb/min, agreeing with
previous measurements [21,22,36]; ,42% of the polymerases had
entered a paused state for an average time of 6 min [34]; and an
average retention time (after end of elongation) of 50 s before
release from the transcription site (Figures S9 and S10) [41]. We
found that the number of genes in the array and the initiation rate
had no effect on the measured kinetic results, due to the
normalization of the data to the steady-state pre-bleach signal.
This observation was confirmed experimentally by measuring
FRAP experiments with low amounts of DRB to abrogate
elongation. Indeed, no kinetic effect on E3 or E6 YFP-MS2
FRAP recoveries was observed (Figure S11), while the addition of
SSA even in the presence of DRB transformed E6 kinetics to E3
kinetics, signifying the effect of splicing on the retention of mRNA
at the site of transcription.
We then searched for a reliable fit to the E6 data by keeping the
kinetic parameters of E3 and changing only the time-scale of
transcript release. We found that the average time for a transcript
to remain at the E6 site of transcription was on average ,10 min
(Figure 6F). This is in agreement with the actinomycin D
experiment that showed a 10 min difference in transcript
clearance times between E3 and E6 (Figure 6D). We also used
the simulations to calculate the ratio of polymerases to nascent
transcripts on the active genes, and compared to the experimental
data. The simulation showed a 3-fold increase in this ratio on the
E6 gene, similar to the result obtained with quantitative FISH
(Figure 6E).
We then used this simulation to examine the intron/exon ratio
on the different genes. In this experiment (Figure 4A) we found a
gradual increase in intron signal at the transcription sites that
correlated to the number of introns in each of the genes. The
simulation output was compared to these RNA-FISH measure-
ments. The simulation provided a ratio between the number of
polymerases/transcripts present on the duplicated intron 2 region
and the number of transcripts that had already passed through the
CFP region. Simulations were run for the different genes with the
abovementioned kinetic parameters assigned to E3 (short retention
time). Since this experiment follows the polymerase moving along
the genes ( = elongation), we expected an increase in the intron/
exon ratio from E1 to E6 genes. Indeed, the simulation showed the
same increment in intron/transcript ratio as seen in the
experimental results (compared in Figure 6G). However, when
the calculated long retention kinetics at the end point of the gene
was included in the simulation of E6 kinetics, we obtained an
output that showed a low intron/exon ratio, which did not agree
untreated E3 cell. RNA-FISH was performed to the MS2 region of the mRNAs (yellow). (E) FRAP recovery curves of YFP-MS2 at the transcription sites of
untreated and SSA-treated E3 and E6 cells. (F) ChIP analysis of Pol II distribution along the E6 gene in untreated (red bars) and SSA-treated (green
bars) cells. Boxes under the schemes indicate primer positions. The data were normalized to the promoter by setting the promoter value at 100%. A t-
test for each primer set showed no significant differences (p.0.05).
doi:10.1371/journal.pbio.1000573.g005
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with the experimental data (Figure 6G). Therefore, the continuous
flow of intron generation observed with the simulation, in contrast
with the slow kinetics of the transcript, imply that the release time
of the transcript from the gene site depends on splicing and not on
the polymerase kinetics.
Discussion
Gene expression profiles are influenced by the presence or lack
of an intron. It has been known for many years that the addition of
an intron into the cDNA of a gene sequence enhances its
expression [50]. Indeed, the act of intron removal can have effects
on the initiation of transcription, mRNA polyadenylation, mRNA
export, and the cytoplasmic fate of the transcript such as
translation, mRNA localization, and mRNA turnover [51]. For
instance, several studies have demonstrated that the presence of an
intron in the pre-mRNA and subsequent splicing can elevate the
rates of mRNA export and thereby the accumulation of message in
the cytoplasm [52–54]. Hence, the presence of an intron exerts an
overall positive influence on gene expression.
How does intron removal affect the levels of transcription and
mRNA production? Some level of regulation can be found on the
DNA itself, for instance by intronic sequences that modulate
nucleosome assembly in the vicinity of the promoter [55]. Splicing
signals in the 59 promoter-proximal intron can stimulate
polymerase II initiation, processivity, and recruitment of tran-
scription factors [56–59], and complexes containing transcription
and splicing factors have been identified [60]. Nonetheless, the
increase of Pol II activity on intron-containing genes versus
intronless genes was modest [56]. Recently, the depletion of the
SR protein SC35 in cells was shown to attenuate the elongation of
Pol II within the gene sequence [61].
In this study we wished to examine the effects of splicing on Pol
II elongation in vivo, independent of promoter influences and
transcriptional initiation events. Therefore, all the gene constructs
were controlled by the same inducible promoter, and elongation
kinetics were examined within the gene as far as possible from the
initiation site. Elongation rates were measured immediately
downstream of the region transcribing the exon-intron-exon
elements, or in other words we could monitor the polymerase
speed as it moved along the DNA after the splicing codes in the
pre-mRNA had already been synthesized. This meant that
polymerase movement towards the 39-end of the gene was
occurring simultaneously with splicing events accompanying the
newly synthesized pre-mRNA. We measured intron accumulation
on the active transcription sites that was dependent on intron
numbers.
The presence of various splicing machinery factors at the
transcription sites was detected only when the gene loci were
actively transcribing. Furthermore, RNA-FISH to intronic and
exonic sequences demonstrated the presence of the introns only at
the sites of transcription and not in the nucleoplasm, signifying
that this is the location of the removal of these introns. However,
when splicing was inhibited with Spliceostatin or Meayamycin,
intron-containing pre-mRNA could be detected also throughout
the nucleus, in particular within nuclear speckles, as previously
described for SSA [48]. The intronless E1 mRNA was not affected
by these treatments. Splicing factors associated with the actively
transcribing genes belonged to the U snRNP family, including
snRNAs (U1, U2, U4, U5, U6) and protein components (U1A,
U1-70K, U2AF65). Also SR proteins such as SC35, SF2/ASF,
and 9G8 were recruited to the active transcription sites upon
activation. Other factors detected at the sites were the transcrip-
tion/splicing-related protein TLS/FUS, splicing regulator PTB,
the elongation regulator cyclin T1, and polyA-binding protein 2
(PABP2). However, factors like PSF and p54nrb [62] previously
demonstrated to be associated with the Pol II CTD [63] were not
detected at the transcribing genes, nor were they pulled down with
a purified polymerase [46]. Distinguishing between the two
approaches might hint to transcription factor dynamics. While
purified protein complexes can give an idea of the ‘‘presence’’ of a
factor in a transcription complex, the imaging assays can indicate
the longevity of ‘‘residence time’’ at the active gene. The fact that
these factors were not identified accumulating on the transcribing
gene arrays using antibodies to the endogenous proteins could
indicate short-lived or low-affinity interactions with other factors
that do associate with the actively transcribing gene.
In this study we examined spliceosomal recruitment to
comparable intron-containing genes as well as an intronless gene.
As anticipated, spliceosomal factors were not found on the active
transcription site of an intronless gene, except for components of
the U1 snRNP. These data are in agreement with a recent report
that quantified the recruitment of splicing factors to an intron-
containing gene in which the splice sites were mutated and
therefore did not undergo splicing [64]. In that study the
recruitment of U1 snRNA and U1-70K were detected on the
gene. In our analysis the intronless E1 gene does not contain any
splice sites and therefore strengthens the notion that U1 snRNP is
associated with the CTD of Pol II by default and presumably
accompanies the polymerase during transcription in order to scan
for the presence of a 59 splice site. Only when such positive
identification of splicing signals has occurred will the rest of the
splicing machinery be recruited to the pre-mRNA.
We quantified an increased accumulation of spliceosomal
components on the pre-mRNA that was dependent on the
number of introns within the gene sequence. These observations
assist in understanding the dynamics of spliceosome assembly on
multiple introns and would be consistent with the scenario of a
step-wise model of spliceosome assembly on each intron [65], as
well as exon-tethering by the polymerase [66]. Our live-cell
analysis suggests that the polymerase does not wait for splicing to
Figure 6. RNA splicing leads to retention of the pre-mRNA on the transcription site. (A) RNA FISH in an E3 cell with a polyT probe (red) and
an MS2 probe (yellow) showing that polyadenylated mRNAs were formed and were present on the transcription sites. (B) Recruitment of GFP-PABP2
(pseudocolored red) to the transcription site labeled with YFP-MS2 (yellow). Plots on the right in (A) and (B) depict the degree of colocalization of the
signals at the transcription site across the line (bar, 5 mm). (C) The ratio of the RNA-FISH signal of polyA to the last exon on the E3, E4, and E6 active
transcription sites, showing no aberrant accumulation of transcripts without polyA signal. (D) Half-time of release of mRNA from transcription sites
following actinomycin D treatment (time measured from ActD addition) in E3 (n = 7) and E4 (n = 7) cells compared to E6 cells (n = 8). Inset shows
two sample time-series of transcription site inactivation and the exponential fit from which half-times of clearance were calculated (blue, E3; red, E6).
(E) The ratio between the polymerase signal and the first exon on the E3, E4, E6, and SSA-treated E6 genes. Each red dot represents the ratio of
intensities measured on a single transcription site. The scheme at the top shows the polymerase antibody (red) and the mRNA (FISH exon 1, yellow).
(F) YFP-MS2 FRAP data and the fitted simulation of the E3 and E6 genes. The calculated residuals of the fit are presented in the inset. (G) RNA-FISH
ratio of intron 2 to the last exon at the transcription site in E1, E3, E4, and E6 cells. The experimental data points (pink, from Figure 4A) were compared
to the simulation output (red) of the same experiment. Simulations were performed with either short (50 sec, E3 kinetics; E1, E3, E4, E6) or long
(10 min, E6 kinetics; E6 rightmost point) transcript retention times.
doi:10.1371/journal.pbio.1000573.g006
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take place but rather runs ahead such that more introns
accumulate. Together with the exon-tethering model it would
mean that exons are being held through the CTD and thereby
recruiting the spliceosome for each splice site.
The kinetic approach we used to measure Pol II transcription
kinetics enables the quantification of elongation that is free of
influences of initiation at the promoter [34]. The region in which
elongation is measured is the MS2 portion of the mRNA in which
the generation of each additional MS2 stem-loop results in an
increase of YFP-MS2 signals on the transcription site. We inserted
the MS2 region downstream of the exon-intron-exon modules and
at the 39-end of the mRNA, thereby monitoring the elongating
polymerase when associated with the splicing machinery. When
we compared the elongation kinetics of the polymerase moving
through the MS2 region after transcribing an E3 or E4 mRNA, we
found that the kinetics were similar and in fact did not differ than
when transcribing an intronless E1 mRNA. A recent study
examining transcription of a variety of endogenous genes along
intronic and exonic regions using quantitative RT-PCR has shown
that polymerase rates were similar on all genes and did not differ
when transcribing intron or exon regions [21].
By generating a gene with many and closely spaced introns and
exons (E6), we created a situation in which the transcription
machinery should have reached the end of the gene before full
splicing of the transcript was completed. Although the generation
of the E6 and E4 genes required the duplication of intron 2 and
the flanking splice sites, we did not find that this had an effect on
the splicing outcome (RT-PCR) of E6 and E4 pre-mRNAs, nor on
the expression levels of the CFP-peroxisome protein product. Also,
there was no indication of aberrant localization of the E6 mRNA
on the transcription site or in nuclear speckles, which could be
indicative of aberrant mRNA production.
The FRAP recovery kinetics of the E6 gene were significantly
slower than the E3 and E4 genes. In order to examine whether the
polymerase was the cause of these slow kinetics, or if the splicing
machinery was responsible, we conducted a series of experiments.
Using splicing inhibitors we saw that the impediment of the slow
kinetics was released and returned to the levels of E3/E4/E1
genes, demonstrating that the slow-down was due to an active
splicing environment. On the other hand, GFP-Pol II recovery
kinetics and ChIP distribution patterns demonstrated that the
polymerase was not paused or hindered during elongation. Use of
actinomycin D that inhibits transcription by intercalating into the
DNA and obstructing the path of the polymerase demonstrated
that the clearance of the mRNAs from the E6 gene was slower.
These transcripts were polyadenylated as seen by recruitment of
PABP2 and the presence of polyA tails. The four different
transcripts showed polyA accumulation on the transcription sites
implying that the transcripts remained attached to the gene until
39-end processing occurred. The quantification of the ratio of
polymerase to nascent transcripts showed that there was
accumulation of pre-mRNAs on the E6 gene, but not on the
other genes. This accumulation was alleviated when splicing was
inhibited. Together with parameter estimation by the simulation
we demonstrate that unspliced E6 transcripts are retained at the
site of transcription for up to 10 min before being released.
The plausibility of a co-transcriptional splicing mechanism can
be imagined just by the fact that human gene exons tend to be
short compared to extremely larger intronic sequences [67], and
genes contain an average of 5–12 exons [68]. This means that if
co-transcriptional splicing did not take place, then the splicing
machinery would have to hold back until transcription has
completed. This would not make much biological sense, especially
when envisaging the transcriptional timeframe of very large genes
such as the dystrophin gene, which lies in the range of 16 h [69].
In fact it has been proposed that the immediate association of U1
snRNP and splicing factors with the emerging pre-mRNA is a
means to block the association with hnRNPs, which are splicing
inhibitory proteins [46]. We demonstrated that the polymerase
activity is uncoupled from splicing once transcription has
terminated. In a scenario in which transcription has ended and
splicing continues, the pre-mRNA and splicing machinery are
retained at the site of transcription until the completion of splicing.
Materials and Methods
Plasmid Construction
E4 generation: The E3 construct (termed E3-minus in [37]) was
digested with BstXI. Re-circularization was prevented by Shrimp
Alkaline Phosphatase (Fermentas). An adaptor composed of the
hybridized A1 & A2 sequences was ligated using T4 DNA ligase
(5u/ml, Fermentas, Ontario, Canada). A1:TTGATATCACC-
GGTGGGCCCGGAAAAGAATTCGTCCATCACT
A2:ATGGACGAATTCTTTTCCGGGCCCACCGGTGAT-
ATCAAAGTG
The adaptor was EcoRV/BstXI digested, and a PmlI/BstXI
intron2-exon3 insert that was separately removed from E3 was
then ligated into the adaptor to generate E4.
E6 was constructed using the same strategy but on the E4
construct. E1 was generated by first digesting the E3 plasmid
BstXI/SacII, followed by ligation with an adaptor composed of A9
& A10.
A9:AAGCTTTGATCAGCGGCCGCATCACT
A10:GGTTCGAAACTAGTCGCCGGCGTA
RNA extractions were carried out with the RNeasy mini kit
(Qiagen). cDNA was synthesized using the RevertAidTM First
Strand cDNA Synthesis Kit and an oligo(dT) primer (Fermentas).
RT-PCR and sequencing of the correctly spliced mRNAs were
performed with primers to the first exon and last exon regions.
A3: AGCAACCTCAAACAGACACC
A4: GGTCTTGTAGTTGCCGTCGT
Other plasmids used in this study were: RFP-LacI, CFP-LacI,
YFP-MS2(-NLS), GFP-Pol II [34], (NES-)YFP-MS2(-NLS) [36],
MS2-mCherry, GFP-PABP2, GFP-PTB, GFP-TLS, and GFP-
cyclin T1.
Cell Culture and Transfections
Human U2OS osteosarcoma Tet-On cells (Clontech) were
maintained in low glucose Dulbecco’s modified Eagle’s medium
(DMEM, Biological Industries, Israel) containing 10% fetal bovine
serum (FBS, HyClone, Logan, UT). For transient transfections,
cells were transfected with 1–5 mg of plasmid DNA and 40 mg of
sheared salmon sperm DNA (Sigma) using electroporation (Gene
Pulser Xcell, Bio-Rad, Hercules, CA) or with FuGENE 6
transfection reagent (Roche). Stable co-transfections were per-
formed by electroporation of the E genes together with a 256 lacO
repeat plasmid and a puromycin resistance plasmid using a
1:10:10 ratio (puromycin res., lacO, E gene). Cells were cultured
for 1–2 d without selection and then selected for 2–3 wk with
100 mg/ml puromycin (AG scientific, San Diego, CA). Single
colonies were picked and positive clones were selected after the
addition of doxycycline (1 mg/ml) and identification of CFP-
peroxisomes and by transient transfection of RFP-LacI and YFP-
MS2. For drug treatments cells were imaged before and right after
the addition of 5 mg/ml actinomycin D (Sigma). For DRB
treatment, cells were treated with 20 mg/ml for 2 h before imaging.
For splicing inhibition, cells were photobleached before and after
incubation with 100 ng/ml of Spliceostation for 6 h, kindly
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provided by Minoru Yoshida (RIKEN Advanced Science
Institute, Japan), or Meayamycin (300 nM) for 6 h before imaging,
kindly provided by Kazunori Koide (University of Pittsburgh,
USA).
qPCR
gDNA was isolated using the PUREGENETM DNA Purifica-
tion System (Gentra). For the generation of standards a 10-fold
dilution was prepared. Primers used for the amplification of CFP
region were GGATCACTCTCGGCATGGAC (forward) and
TGCACATACCGGAGCCATTG (reverse). Primers used for the
human b-globin reference gene were CAGTGCAGGCTGCC-
TATCAGA (forward) and GAATCCAGATGCTCAAGGC-
CCTT (reverse). The reaction (20 ml total volume) contained 16
SYBR green mix (Thermo scientific, Waltham, MA), 1 ml of
gDNA dilution, and 0.5 mM of each primer and water. The
reaction was performed using the Chromo4TM Real-Time
Detector (Biorad) following the protocol: 15 min at 95uC for
enzyme activation, followed by 40 cycles consisting of 15 s
denaturation at 92uC, 10 s annealing at 64uC, and 20 s extension
at 72uC. Fluorescent signal was measured at the end of each cycle.
A final dissociation stage was performed to generate a melting
curve for verification of amplification product specificity. For
calculating the gene copy number, we first calculated the reaction
efficiency for each set of primers by using triplicates of 56dilutions
of gDNA, using the provided software Opticon2 (Biorad). We
measured the average cycle number for each gDNA sample using
both primer sets and calculated the concentration (Qc) of each
reaction by: Qc~efficiancy
{cycle time. Then we could calculate
the gene copy number of the samples:
Qc(CFP primers)
Qc(beta globin)
2
We verified that the U2OS cell line has only two alleles of the b-
globin gene by comparing to a non-cancerous cell line.
Chromatin Immunoprecipitation and Quantitative PCR
ChIP and quantitative PCR were performed as previously
described [18]. After an overnight induction with 1 mg/ml
doxycycline, cells were harvested and lysed in SDS lysis buffer.
Protein concentration was determined via Amido Black and 1 mg
total protein was used per IP. For SSA treatment, cells were
treated with 100 ng/ml SSA prior to lysis. Antibodies used for the
ChIP were 5 mg/IP CTD4H8 against RNA polymerase II (Santa
Cruz Biotechnology, SC-47701) and 10 mg/IP non-immune
mouse IgG (Sigma, I5381) for the mock ChIPs. Uncrosslinking
and Proteinase K treatment (100 mg/IP) were performed for 6 h at
65uC. DNA was extracted using the Qiagen PCR purification kit
and used as a template for quantitative PCR. Primer sequences
used in the qPCR analysis can be obtained upon request. For each
amplicon, ChIP signal relative to input was calculated based on
the Ct values. The values obtained for control antibody were then
subtracted from those of specific antibodies. Thus, the following
equation was used: 2(Ct(Input)2Ct(spIP))22(Ct(Input)2Ct(cIP)),
where: spIP2IP with specific antibody and cIP2IP with a control
antibody. Values obtained for amplicons within gene regions were
further normalized to the promotor region.
Immunofluorescence
Cells grown on coverslips were fixed for 20 min in 4% PFA and
then permeabilized in 0.5% Triton X-100 for 3 min. After
blocking with 5% BSA, cells were immunostained for 1 h with:
mouse anti-RNA Pol II antibody (clones H14, H5, 8WG16
(Covance)), mouse anti-SF2/ASF (Zymed), mouse anti-PSF (B92,
Sigma), mouse anti-2,2,7-trimethylguanosine (TMG) (Mercury),
rabbit anti-U1A, rabbit anti-U2AF65 (Abcam), mouse anti-SC35
(Sigma), mouse anti-9G8, and mouse anti-p54nrb (BD Bioscience).
After subsequent washes the cells were incubated for 1 h with a
secondary Ab: Cy5-labeled goat anti-mouse IgG, Cy3-labeled goat
anti-mouse IgG, FITC-labeled anti-mouse IgM (Jackson Immu-
noResearch, West Grove, PA), Alexa488-labeled goat anti-mouse
IgG, Mouse anti-rabbit Alexa488, and rabbit anti-mouse
Alexa594 (Molecular Probes). Coverslips were mounted in
mounting medium.
Fluorescence In Situ Hybridization
RNA FISH was performed on dox activated cells as previously
described [70] using 10 ng (probe per slide) of 59-Cy3 or Cy5
labeled fluorescent probes, as follows:
CFP: ATATAGACGTTGTGGCTGATGTAGTTGTACTC-
CAGCTTGTGCCCCA
GGATA
Exon1: CATGAATTCTTTGCCAAAGTGATGGGCCAGC-
ACACAGACCAGCA
CGTTGC
Intron1: TCTCGTGACAGAGAAGGGTGTAAAAGCTTC-
TAGCCTTTTCTCTTA
CCTTA.
Intron2: TAGCAAAAGGGCCTAGCTTGGACTCAGAAT-
AATCCAGCCTTATC
CCAACC
MS2: CTAGGCAATTAGGTACCTTAGGATCTAATGAA-
CCCGGGAATACT
GCAGAC
PolyA: an oligo(dT) probe
The U snRNA set of probes containing 5-amino-allyl
thymidines (Eurogentec) were labeled with Cy3 or Cy5 mono-
reactive dyes (GE Healthcare).
U1-1: CtGGGAAAACCACCtTCGTGATCAtGGTATCTC-
CCCtGCCAGGTAAGtAT
U1-2: CGAACGCAGtCCCCCACtACCACAAATTAtGCA-
GTCGAGtTTCCCACAtT
U2: AGtGGACGGAGCAAGCtCCTATTCCAtCTCCCTG-
CtCCAAAAATCCATtT
U4-1: tAGCAATAAtCGCGCCTCGGAtAAACCTCATtGG-
CTACGATACtGCCACT
U4-2: AGACtGTCAAAAATtGCCAATGCCGACtATATT-
GCAAGtCGTCACGGCGGtA
U5: GGCAAGGCTCAAAAAATTGGGTTAAGACTCAGA-
GTTGTTCCTCTCCACGGTA
U6: CGtGTCATCCTtGCGCAGGGGCCAtGCTAATCTT-
CtCTGTATCGTtCCAA
7SK snRNA: TtGGATGTGTCTGGAGTCTtGGAAGCTT-
GACTACtT
In some cases, an immunostaining was performed after FISH
using the standard protocol.
Fluorescence Microscopy, Live-Cell Imaging, and Data
Analysis
Wide-field fluorescence images were obtained using the Cell‘R
system based on an Olympus IX81 fully motorized inverted
microscope (636Plan-Apo, 1.42NA and 1006Plan-Apo, 1.4NA)
fitted with an Orca-AG CCD camera (Hamamatsu), rapid
wavelength switching, active focus control (ZDC), a motorized
stage (Scan IM, Ma¨rzha¨user, Wetzlar-Steindorf, Germany), and
driven by the Cell‘R software. The microscope is equipped with
an on-scope incubator which includes temperature and CO2
control (Life Imaging Services, Reinach, Switzerland).
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For time-lapse imaging of ActD treatment, several cell positions
under non-treated conditions were chosen and recorded. Then
5 mg/ml of actinomycin D was added and cells were imaged every
5 min for 1.5 h.
Images and videos were analyzed using self-written ImageJ
software macros (National Institutes of Health, Bethesda, MD).
The co-localization intensity profile was generated with an ImageJ
macro. The channel intensity correlation was generated by
Matlab. The 4D image sequences were sum Z-projections. The
transcription site was tracked and the mean intensity was
measured at every time-point by finding the local maxima of the
red (RFP-LacI) for each time point in a specific region of interest
(ROI). The background was taken from an ROI outside of the cell
and subtracted from all other measurements. Photobleach
correction was obtained using another area in the nucleus or in
another nucleus. Images acquired before drug addition were used
as the initial conditions for normalization of the data. The half-
time of site inactivation was calculated for each transcription site
using Matlab. Each transcription site measured intensity dataset
was fitted to a bi-exponential equation f(x) = a*exp(b*x)+c*exp(d*x).
We then searched for the t1
2
, which brings the equation to the value
of f (t1
2
)~
f (t0){f (tss)
2
zf (tss). For each E cell type we collected at
least 7 cell transcription site measurements, and the averages and
standard error were calculated.
FRAP
FRAP experiments were performed using a 3D-FRAP system
(Photometrics) built on an Olympus IX81 microscope (636Plan-
Apo, 1.4 NA) equipped with an EM-CCD (Quant-EM, Roper),
405 & 491nm lasers, Lambda DG-4 light source (Sutter), XY&Z
stages (Prior), and driven by MetaMorph (Molecular Devices).
Experiments were performed at 37uC with 5% CO2 using a live-
cell chamber system (Tokai). Before and after the bleaching, cells
were imaged in the YFP channel for the detection of YFP-MS2
(mRNPs) and in the CFP channel for the detection of CFP-lacI
(genomic locus). For each acquisition, 7 Z-slices were taken every
350 nm. The active transcription site was bleached using the
491 nm laser. Six pre-bleach images were acquired. Post-bleach
images were acquired in a sequence of 3 time frequencies: 15
images every 3 s, 15 images every 6 s, and 26 (or 45 for long
experiments) images every 30 s.
Experiments were performed on two additional systems to verify
their consistency: (1) a similar 3D FRAP system in the Darzacq
laboratory under the same conditions; (2) Zeiss LSM 510 Meta
laser scanning confocal microscope (Plan-Apochromat 636, 1.4
NA oil objective (Jena, Germany)). Cells were scanned at 488 nm
for GFP-MS2 or 514 nm for YFP-MS2, together with a 543 nm
laser for the detection of RFP-lacI at the genomic locus. Post-
bleach recovery images were acquired every 1 s.
The experiments were analyzed using self-written ImageJ
macros that sum the projected Z-stacks at every time-point, and
track and measure the mean intensity of the transcription site at
every time-point by finding the local maxima in a specific region of
interest (ROI). For each time-point, the background taken from a
ROI outside of the cell was subtracted from all other measure-
ments. T(t) and I(t) were measured for each time-point as the
average intensity of the nucleus and the average intensity in the
bleached ROI, respectively. The average of the pre-bleach images
used as the initial conditions are referred to as Ti = nuclear
intensity and Ii = intensity in ROI before bleaching. Ic(t) is
the corrected intensity of the bleached ROI at time t [42,71]:
Ic tð Þ~
I tð ÞTi
IiT tð Þ
Data from at least 10 experiments for each cell-line were
collected and the averaged FRAP measurements were fitted to the
simulation.
The diffusion of the YFP-MS2 protein during the FRAP
analysis was disregarded since the diffusion rate of free
nucleoplasmic YFP-MS2 is very rapid, while the bound YFP-
MS2 is associated with high affinity to the mRNA, and does not
detach, diffuse, and bind again at the transcription site [34,41,42].
Quantitative RNA FISH and Immunofluorescence Analysis
Quantitative RNA FISH was used to compare the ratio of FISH
signals from two different probes in two different channels.
Although each cell line had a different number of gene-copies
integrated, the ratio per transcript is comparable. Z stacks (91
slices, 200 nm steps) of the immunostained or RNA FISH samples
were collected. Images were acquired for the quantification of the
exons, introns, U snRNAs, or Pol II present on the transcription
sites. Each experiment in which all E cell types were analyzed were
acquired under the same conditions and on the same day. Images
were deconvolved using a point spread function (PSF) based
deconvolution algorithm Huygens Essential II (Scientific Volume
Imaging, Hilversum, The Netherlands). The sum of pixel values at
the transcription site in each channel were measured using Imaris
(Bitplane, Saint Paul, MN), and the ratio between the channels is
presented.
Computational Simulation
Monte Carlo simulations (Matlab) of the transcriptional process
were based on the mechanistic models of [34,41]. The simulation
was used to simulate the FRAP experiments, and by fitting the
simulation to the experimental data we could retrieve the kinetic
parameters of the process. The simulation performs stochastic
decisions by using random numbers obtained from the simulation
and checks whether they are smaller than the kinetic parameters.
For each gene (E1, E3, E4, and E6), we generated a set of identical
arrays where the length of each array corresponded to the length
of the gene. RNA polymerases were implemented as counters that
‘‘slide’’ over these arrays. ‘‘Transcriptional initiation’’ occurred
stochastically at a given ‘‘initiation rate,’’ after which a constant
speed of elongation was retained. Whenever a polymerase moves
through the ‘‘MS2 region’’ of the gene, the polymerase/transcript
accumulates a ‘‘fluorescent signal’’ that was maintained until the
end of the gene. Polymerases were stochastically released at a
given termination rate [41]. Polymerases could also randomly
enter and exit a paused state [34]. The simulation reached steady
state after long times, as expected.
To simulate the FRAP experiments, we tracked the total
‘‘fluorescent’’ signal. After the system entered steady state, we
‘‘bleached’’ (deleted) the fluorescent molecules and measured the
buildup of ‘‘fluorescent’’ signal during the recovery. The signal was
normalized as in the FRAP experimental procedure. The kinetic
parameters, namely, the elongation speed, the termination rate,
and the rates of entering and exiting the paused state, were chosen
as those that best fit the experimental FRAP data. We found that
the number of gene arrays and the initiation rate had no effect on
the measured kinetic results, due to the normalization to the pre-
bleach signal.
To find the above four kinetic parameters that best fit the
experimental data we had to explore a four-dimensional
parameter space. For each configuration, the mean square
difference (MSD) between the simulated FRAP curve and the
experimental curve was calculated (Figure S10). For the E3 gene,
the kinetic parameters that gave the best fit (lowest MSD) were:
3.6 kb/min, ,42% of the polymerases entering a paused state for
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an average of 6 min, and transcript retention of 50 s after the end
of elongation. To obtain the kinetic parameters for the E6 gene,
we used the best fit values of the E3 elongation speed and pausing
transition rates, and changed only the termination rate.
Supporting Information
Figure S1 Transcriptional induction of the different cell
lines. The cell lines containing the stably integrated E1, E3, E4,
and E6 genes were transcriptionally induced by dox for 12 h.
RNA-FISH with a probe to the MS2 region shows the
transcription sites (yellow). The CFP protein product is targeted
to peroxisomes (cyan). DIC on the right (bar, 5 mm).
Found at: doi:10.1371/journal.pbio.1000573.s001 (3.64 MB TIF)
Figure S2 Recruitment of RNA processing factors to
active transcription sites of E3 cells. The gene locus was
identified with RFP-LacI (red) and the recruitment of endogenous
Pol II (green) was identified by (A) 8WG16 Ab (specific to the
CTD repeats) and (B) H5 Ab (CTD phosphorylated on serine 2).
Active transcription sites (MS2, yellow) can be seen together with
immunofluorescence (red) with (C) anti-TMG identifying the cap
structure of snRNAs. (D) RNA-FISH to U4 snRNA and (E) U5
snRNA, together with a probe to the MS2 region (yellow). (F)
Immunofluorescence with anti-U1A, (G) anti-U2AF65, (H) anti-
SF2, (I) anti-9G8, and (J) anti-SC-35; together with the YFP-MS2
protein. Enlargements show the merged signals at the transcription
sites. Plots depict the degree of co-localization of the signals at the
transcription site across the depicted line (bar, 5 mm).
Found at: doi:10.1371/journal.pbio.1000573.s002 (3.54 MB TIF)
Figure S3 Recruitment of transcription-related factors
to active transcription sites of E3 cells. (A) Transiently
expressed GFP-TLS, (B) GFP-PSF, (C) GFP-p54nrb, (D) GFP-
PTB, (E) GFP cyclin T1 (pseudocolored red), imaged together with
YFP-MS2. (F) RNA-FISH to 7SK RNA (red) and MS2 repeats
(yellow). Enlargements show the merged signals at the transcrip-
tion sites. Plots depict the degree of colocalization of the signals at
the transcription site across the depicted line (bar, 5 mm).
Found at: doi:10.1371/journal.pbio.1000573.s003 (3.78 MB TIF)
Figure S4 Recruitment of RNA processing factors to
transcription sites of the intronless E1 gene. Immunoflu-
orescence (red) with (A) anti-TMG that identifies the cap of
snRNAs, (B) anti-U1A, and (C) anti-U2AF65, together with
the mRNA seen by transfected YFP-MS2 labeling (yellow).
(D) RNA-FISH to U4 snRNA and (E) U5 snRNA, together with
a probe to the MS2 region (yellow). Enlargements show the signals
at the transcription sites. Plots depict the degree of co-localization
of the signals at the transcription site across the depicted line
(bar, 5 mm).
Found at: doi:10.1371/journal.pbio.1000573.s004 (1.67 MB TIF)
Figure S5 Comparison of FRAP results on E3 cells
performed on different microscopes. The recovery of
photobleached YFP-MS2 on actively transcribing sites was
monitored in E3 cells using: (a) a Zeiss confocal microscope; (b)
a 3D FRAP system in our laboratory (system 1); and (c) a 3D
FRAP system in the Darzacq laboratory (system 2) (average from
at least n.10 in each experiment).
Found at: doi:10.1371/journal.pbio.1000573.s005 (0.14 MB TIF)
Figure S6 Genomic positioning and gene copy number
have no effect on the measured kinetics. (A) FRAP results
of different E6 clones (E6-3 and E6-22-22) performed on different
microscopes. (B) Real-time PCR on genomic DNA was used to
quantify the number of genes integrated into each gene array gene
repeats: E3 = 24, E4 = 5, E6-22-22 = 40, E6-3 = 9 with
standard deviation.
Found at: doi:10.1371/journal.pbio.1000573.s006 (0.46 MB TIF)
Figure S7 Analysis of FRAP curves. FRAP recovery
curves of the E3 transcription site show bi-phasic
kinetics, which points to two parallel processes. The
red line is the curve fit for the sum of the two-exponential equation
and shows a better fit than the green line that was fitted to one
exponential. The yellow line presents the fast phase (70%) and the
pink line is the slow phase (30%).
Found at: doi:10.1371/journal.pbio.1000573.s007 (0.15 MB TIF)
Figure S8 The effects of splicing inhibitors on the
elongation kinetics. (A) Inhibition of splicing by Meayaymycin
(6 h) showed that the unspliced pre-mRNA was distributed
throughout the cell and in speckles (RNA-FISH on E6 cells) and
was retained in the nucleus (bottom), whereas in untreated cells
pre-mRNA was detected only at the site of transcription. (B) FRAP
recovery curves of untreated and Meayamycin-treated E6 cells
shows similar kinetics as E3 cells. (C) The treatment of cells with
SSA for 9 h followed by FRAP analysis of GFP-Pol II recruited to
the transcription sites shows that splicing inhibition did not affect
polymerase kinetics.
Found at: doi:10.1371/journal.pbio.1000573.s008 (1.51 MB TIF)
Figure S9 Searching the kinetic parameter space for the
best fit to experimental data. (A) Simulation plots of an
elongating (red) or paused (blue) polymerase population. Top part
shows an example of an experiment in which the MS2
fluorescence accumulates (arrow) and is then released. Bottom
part shows the accumulation of fluorescence in the MS2 region
(left arrow) as well as a stochastically paused polymerase (right
arrow). (B,C) The simulations rely on four kinetic parameters: the
elongation speed, the termination time, and entering and exiting
rates of the paused state (Kin, Kout). To find the best fit to the
experimental data, the kinetic parameters were varied in a
systematic way. The parameters were plotted two at a time
because the parameter space is four dimensional. (A) Plot of the
mean square difference (MSD) between the experimental FRAP
curve and the simulated curve for each pair of elongation speed
and termination time. (B) Similar analysis with the pausing
transition rates. The MSD is color coded: the dark blue
corresponds to parameter combinations that result in the best fit
to the experimental data.
Found at: doi:10.1371/journal.pbio.1000573.s009 (1.25 MB TIF)
Figure S10 Exploring how the simulation parameters
affect the kinetics. (A) Changes in the elongation speed. (B)
Changes in the probability to enter or exit a paused state changed
the pausing time during transcription, and the average percentage
of polymerases that paused in steady state. (C) Changing only the
termination time.
Found at: doi:10.1371/journal.pbio.1000573.s010 (0.64 MB TIF)
Figure S11 Low DRB does not affect kinetics on E3 and
E6 genes. No change in the FRAP recovery kinetics of YFP-MS2
on cells treated with DRB (20 mg/ml for 2 h before imaging): E3
cells (brown), E6 cells (dark green), or E6 cells with SSA (cyan)
SSA; compared to untreated E3 (blue) and E6 (light green) cells.
Found at: doi:10.1371/journal.pbio.1000573.s011 (0.14 MB TIF)
Video S1 Transcriptional activation of E3 (top) and E6
(bottom) cells. The DNA locus is tagged with CFP-LacI and the
cytoplasmic peroxisomes are also seen in CFP. The mRNA is
tagged with YFP-MS2. As transcriptional induction proceeds, the
transcription sites appear and then mRNAs disperse into the
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nucleoplasm. CFP-peroxisomes appear at later times. Since the
videos were acquired in 3D and the z-stacks covered the cell
volumes, we could show the nuclear CFP-LacI locus in the
beginning of the videos and then later shift to the cytoplasmic
plane that best shows the CFP-peroxisomes. Cells were imaged
15 min after dox addition and the time in the videos is measured
from dox addition. E3, imaged every 15 min; E6, imaged every
20 min.
Found at: doi:10.1371/journal.pbio.1000573.s012 (1.59 MB
MOV)
Video S2 FRAP experiment of an E4 cell. mRNA was
labeled with YFP-MS2. 2D image over time of a summed
projection of a 4D video. Right: Enlarged tracking of the
transcription site. Time zero indicates the bleach time.
Found at: doi:10.1371/journal.pbio.1000573.s013 (0.28 MB
MOV)
Video S3 Addition of actinomycin D to transcribing E6
cells and recording transcription site inactivation over
time. The mRNA was tagged with YFP-MS2 (green) and the
transcription site locus with RFP-LacI (red). Time zero indicates
ActD addition time.
Found at: doi:10.1371/journal.pbio.1000573.s014 (0.94 MB
MOV)
Video S4 Example of a simulation run. Each dot denotes a
polymerase moving along the gene: elongating = red dot, and
stochastically pausing = dot becomes green. When the polymer-
ase terminates and the transcript still remains on the transcription
site, the dot becomes yellow. The bleached polymerase becomes
blue. The x-axis = gene length of E3; in the y-axis each line
represents a gene within the transcription site. Top: a single gene
view. Bottom: an array of 1,000 genes running in parallel. The last
frame contains a graph showing the MS2 intensity measured from
the simulation.
Found at: doi:10.1371/journal.pbio.1000573.s015 (4.30 MB
MOV)
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